Matthew Lindon
Keine laufenden Positionen mehr
Profil
Matthew Lindon worked as a Global Project Leader at AstraZeneca AB.
He also worked as the Chief Scientific Officer at LIDDS AB for a year in 2023.
Prior to his professional experience, he completed his undergraduate degree at the University of Leicester.
Ehemalige bekannte Positionen von Matthew Lindon
Unternehmen | Position | Ende |
---|---|---|
LIDDS AB | Vorstandsvorsitzender | 01.12.2023 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Matthew Lindon
University of Leicester | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LIDDS AB | Health Technology |
Private Unternehmen | 1 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |